NewsRx

Search our medical news database

AIDS Weekly and Law

Susan Hasty, Publisher

Table of Contents . . . April 29th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in AIDS Weekly and Law | Other Publications

Immune Response Corporation - Canadian trial investigates Remune as a drug-sparing therapy in HIV

Memorial Sloan-Kettering Cancer Center - Chemokine receptor 5 dispensable response to Listeria monocytogenes

U.S. Centers for Disease Control and Prevention - CDC grants $21 million to enhance HIV prevention in communities of color

Weizmann Institute of Science - Anti-NeoR6 resistance mutations suggest anti-HIV mechanisms

Boston University - Missed opportunities for addressing HIV testing remain unacceptably high

Carlos III Hospital, Madrid - Risk factors for severe liver fibrosis identified

Children's Hospital of Philadelphia - Research offers intriguing clues to "Trojan horse" gene in HIV infection

Cincinnati Children's Hospital - Role of CD40L dysregulation in HIV-induced APC dysfunction reviewed

Dermik Laboratories - FDA Advisory Panel recommends, with conditions, approval of Sculptra

GSF-National Research Center for Environ & Health - MVA-HIV-1 nef vaccine elicits T-helper cell responses in HIV patients

Harvard University - Intracellular transport of HIV integrase elucidated

Health Discovery Corp. - Discovery agreement inked regarding AIDS-related dementia

HIV/AIDS - Cheaper AIDS drugs to be available in U.N.-supported nations

HIV/AIDS - Grant benefits Nevada AIDS program

HIV/AIDS - Philadelphia OKs code-based HIV reporting for Philly

Istituto Superiore di Sanita - HIV Nef uses soluble factors to activate macrophage STAT3

Macfarlane Burnet Inst. for Med. Res. & Pub. Hlth - Role of monocytes in latent HIV infection reviewed

National Cancer Institute, Aviano - Complete remission feasible in HIV NHL patients

Natl. Res. Ctr. for Environment & Health, Neuherbe - Nuclear targeting activities of HIV Rev transport signals characterized

New York University - Finding epitopes of HIV-1 that induce protective antibodies remains a challenge

OraSure Technologies, Inc. - FDA approves OraQuick Rapid HIV Antibody Test for use with oral fluid

Partners AIDS Research Center - Children may have enhanced responses to anti-HIV immunotherapy

Rene Descartes University - Phosphorylation motif of HIV Vpu bound to beta-TrCP described

Russian Academy of Sciences - HIV integrase can process a 3'-end crosslinked substrate

Samaritan Pharmaceuticals Inc. - Pharmaceutical company announces development milestones in HIV products

San Raffaele Scientific Institute, Milan - Roles of uPA and uPA receptor in HIV infection reviewed

Temple University - Opioid-induced CCR5 desensitization reduces R5 HIV infectivity

Tibotec Pharmaceuticals, Ltd. - IPM will take over the development of microbicide TMC120

U.S. Agency for International Development - HIV education efforts neglect partner reduction

U.S. Centers for Disease Control & Prevention - Persistent parvovirus B19 infection without chronic anemia reported

U.S. National Cancer Institute - Serum inactivation of SDF-1 prevents inhibition of HIV infection

U.S. National Institutes of Health - M-tropic chimeric SHIV strains in CD4 cell-depleted macaques characterized

Univ. of California, Los Angeles - Doctors likely to delay prescribing antiretrovirals for women, minorities

Univ. of California, Los Angeles - Women, Latinos, poor are more likely to be non-adherent HIV/AIDS patients

University Federico II of Naples - Novel mechanism of naive T-cell anergy induction by HIVenv identified

University of Alabama Hospital - Epidemiology of Aspergillus terreus at university hospital described

University of Amsterdam - Serum samples preferable for PCR-based Kaposi sarcoma diagnosis

University of Bordeaux 2 - Borna disease virus infection confirmed in HIV patients

University of Cincinnati - Noninvasive assay for P. carinii pneumonia monitoring developed

University of London - Nadir B-cell counts correlated with Kaposi sarcoma risk

University of Nebraska - Mitochondrial glutaminase augments glutamate output by HIV-infected macrophages

University of Pisa - Hemolysin production by M. avium strains determined

University of Sydney - Sexually transmissible infections other than HIV reviewed

University of Ulm - Anti-nanobacteria phototherapy ameliorates HIV- and diabetes-related neuropathy

University of Urbino - Fludarabine-loaded RBCs can clear HIV macrophage reservoir

University of Utah Hospital - Oral CMV therapy superior to intravenous treatment

University of Washington - Epidemiology of MDR-TB in HIV patients in Peru described

University of Wisconsin -  C. albicans epithelial adhesion gene identified

ViroLogic, Inc. - VLink online system launched for HIV resistance test reporting

Wistar Institute - DC-SIGN not sole determinant of macrophage HIV transmission

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook